23 commercial health plans now cover SI-BONE's iFuse Implant System

Written by Shayna Korol | August 07, 2018 | Print  |

SI-BONE's iFuse Implant System is now exclusively covered by 23 commercial health plans.

The triangular iFuse Implant System is intended for sacroiliac fusion to treat conditions such sacroiliac joint dysfunction, that are a direct result of sacroiliac joint disruption and degenerative sacroiliitis.

The exclusive positive coverage policies provide access to minimally invasive SI joint fusion with the iFuse Implant System for over 35 million health plan members. Recently, eviCore healthcare published positive recommendation for the use of the iFuse Implant.

More articles on devices and implants:
Orthofix Q2 sales spike 2.4% to $111.5M: 5 observations
Fuse Medical completes Maxim Surgical acquisition
Alphatec sets sights on 12 new product launches: 3 things to know about the rest of the year

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months